Cargando…
Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence
Primary vitreoretinal lymphoma (PVRL) often masquerades as other uveitic diseases. We investigated the aqueous cytokine level changes and the effects of intraocular methotrexate (MTX) in patients with PVRL. In this retrospective consecutive case-series study, we reviewed the records of 14 consecutiv...
Autores principales: | Park, Young Gun, Park, Woo-Kyung, Kim, Rae-Young, Kim, Mirinae, Park, Young-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532210/ https://www.ncbi.nlm.nih.gov/pubmed/33009434 http://dx.doi.org/10.1038/s41598-020-73111-2 |
Ejemplares similares
-
Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment
por: Kim, Rae-Young, et al.
Publicado: (2021) -
Clinical features predictive of vision loss in patients with vitreoretinal lymphoma: a single tertiary center experience
por: Kim, Mirinae, et al.
Publicado: (2023) -
Corneal Epithelial Toxicity after Intravitreal Methotrexate Injection for Vitreoretinal Lymphoma: Clinical and In Vitro Studies
por: Jeong, Yoon, et al.
Publicado: (2020) -
Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients
por: Zhou, Xian, et al.
Publicado: (2020) -
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
por: Anthony, Casey L., et al.
Publicado: (2021)